Related News
Pfizer to buy Allergan for US$160b
Print Edition
PFIZER Inc yesterday said it would buy Botox maker Allergan Plc in a record-breaking deal worth US$160 billion, designed to cut the company’s US tax bill by moving its headquarters to Ireland.
The merger, which will create the world’s largest drugmaker, will delay the Lipitor and Viagra maker’s decision on whether to split by two years to late 2018, Pfizer said.
Investors had been hoping Pfizer would sell off its low-margin generics by 2017 while holding onto its faster growing branded prescription drugs, a move that will be delayed by the time required to integrate Allergan.
Pfizer Chief Executive Officer Ian Read will hold that position at the combined entity, while Allergan CEO Brent Saunders will be president and chief operating officer.
The deal values Allergan’s shares at US$363.63 each, about 16 percent more than their closing price of US$312.46 on Friday.
Allergan shareholders would receive 11.3 shares in the combined company for each of their shares.
Pfizer stockholders can get cash or one share of the combined company for each of their shares, but the aggregate amount of cash must range from US$6 billion to US$12 billion.
While the deal is structured as Allergan buying Pfizer, Pfizer would retain control of the company.
The tax aspect of the deal has been seen as critical. The US corporate tax rate of 35 percent is among the world’s highest, while Ireland’s is just 12.5 percent.
Upon the closing of the transaction in the second half of 2016, the companies said the combined company would maintain Allergan’s Irish legal domicile.
Plans call for four current directors of Allergan, including Saunders and Executive Chairman Paul Bisaro, to join Pfizer’s 11-member board, the companies said in a joint release.
The US Treasury, concerned about losing tax revenue, has been taking steps to clamp down on tax inversion deals, but experts have said these moves will do little to prevent Pfizer from shifting its domicile.
The businesses of Pfizer and Allergan will be combined under Allergan Plc, which will be renamed Pfizer Plc.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
